Latest News - #Aviewer

The head of the FUND told about the effectiveness of "Avifauna"

Russian anti-coronavirus "avitamin a" better American "Ramdevpir", it is cheaper and comes in tablets, said the head of the Russian direct investment Fund (RDIF) Kirill Dmitriev.

"Aviewer", in which participated the FUND, may 29, received a registration certificate of Ministry of health of the Russian Federation and became the world's first drug against the coronavirus that contains active substance favipiravir, and on 3 June was included in the list of methodological recommendations for the prevention, diagnosis and treatment of new coronavirus infection. RDIF has asked the health Ministry to allow the use of "Avifauna" outpatient those treated for the coronavirus of the house.

The manufacturer has told about the use of "Avifauna" in Russia

Drug "Aviewer" from COVID-19 was applied successfully to treat more than 30 of thousands of Russians in different regions, from the presentation of the company "Chromis", which is the manufacturer of the drug.

"Aviewer" was effectively used by more than 30 thousands of Russian patients in 51 regions of the country", - the document says.

Media called the possible date of receipt "of Avifauna" in the Russian hospital

"Aviewer" can arrive in the Russian hospital on June 11, the newspaper "Izvestia" with reference to the Russian direct investment Fund (RDIF).

The implementation of the drug will occur in contracts with health facilities, so it will not work in the free market, the newspaper notes. It is emphasized that to appoint the drug will be only in hospitals under the supervision of doctors.